Literature DB >> 35173290

Nutritional characteristic of children with inflammatory bowel disease in the nationwide inflammatory bowel disease registry from the Mediterranean region.

Zarife Kuloglu1, Funda Çetin2, Nafiye Urgancı3, Zerrin Önal4, Sinan Sarı5, Hasan Yüksekkaya6, Gönül Çaltepe7, Günsel Kutluk4, Ebru Dumlupinar8.   

Abstract

BACKGROUND/
OBJECTIVES: We analyzed the nationwide pediatric inflammatory bowel disease (PIBD) registry (1998-2016), to evaluate the nutritional status at the time of diagnosis. SUBJECTS/
METHODS: Nine types of nutritional status by the combination of weight-for-length (<2 years)/body mass index (>2 years) and length/height-for-age with three categories (<-2, -2 to 2, and >2 SD) were described. Malnutrition was defined by WHO criteria. Univariate and multivariate regression analysis was used to identify risk factors for malnutrition.
RESULTS: In total, 824 IBD patients (498 Ulcerative colitis (UC); 289 Crohn's Disease (CD); 37 Indeterminate Colitis (IC); 412 male; the median age 12.5 years) were eligible. The prevalence of eutrophy, wasting/thinness, stunting, overweight, tall stature, concurrent wasting/thinness and stunting, tall stature with overweight, tall stature with wasting/thinness, and short stature with overweight were 67.4%, 14.9%, 6.6%, 3.1%, 3.2%, 3.3%, 1.1%, 0.4%, and 0.1%, respectively. The prevalence of malnutrition was 32.7%, indicating a higher prevalence in CD (p < 0.001). Incidence of overweight was less common in the CD than UC and IC (p < 0.001). Multivariate analysis revealed that age of onset (>10 years), prepubertal stage, severe disease activity, perianal involvement, and high C reactive protein level were independently associated with malnutrition in pediatric IBD.
CONCLUSION: We showed the frequency of nutritional impairment in PIBD. The percentage of overweight subjects was lower than the other studies. The age of onset, disease activity, CRP level, perianal involvement, and pubertal stage were associated with a higher risk for developing malnutrition. Our results also confirmed that CD patients are particularly vulnerable to nutritional impairment. CLINICAL TRIAL NUMBER: ClinicalTrials.gov Identifier: NCT04457518.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2022        PMID: 35173290     DOI: 10.1038/s41430-022-01094-6

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.884


  29 in total

1.  Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls.

Authors:  B J Geerling; A Badart-Smook; R W Stockbrügger; R J Brummer
Journal:  Eur J Clin Nutr       Date:  2000-06       Impact factor: 4.016

2.  Overweight and obesity in children with newly diagnosed inflammatory bowel disease.

Authors:  Aleksandra Pituch-Zdanowska; Aleksandra Banaszkiewicz; Marcin Dziekiewicz; Izabella Łazowska-Przeorek; Agnieszka Gawrońska; Kinga Kowalska-Duplaga; Barbara Iwańczak; Beata Klincewicz; Urszula Grzybowska-Chlebowczyk; Jarosław Walkowiak; Piotr Albrecht
Journal:  Adv Med Sci       Date:  2015-08-08       Impact factor: 3.287

3.  Development and validation of a pediatric Crohn's disease activity index.

Authors:  J S Hyams; G D Ferry; F S Mandel; J D Gryboski; P M Kibort; B S Kirschner; A M Griffiths; A J Katz; R J Grand; J T Boyle
Journal:  J Pediatr Gastroenterol Nutr       Date:  1991-05       Impact factor: 2.839

4.  Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II.

Authors:  J M Tanner; R H Whitehouse; M Takaishi
Journal:  Arch Dis Child       Date:  1966-12       Impact factor: 3.791

5.  Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts.

Authors:  Subra Kugathasan; Justin Nebel; Joseph A Skelton; James Markowitz; David Keljo; Joel Rosh; Neal LeLeiko; David Mack; Anne Griffiths; Athos Bousvaros; Jonathan Evans; Adam Mezoff; Susan Moyer; Maria Oliva-Hemker; Anthony Otley; Mariann Pfefferkorn; Wallace Crandall; Robert Wyllie; Jeffrey Hyams
Journal:  J Pediatr       Date:  2007-08-24       Impact factor: 4.406

6.  Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study.

Authors:  Dan Turner; Anthony R Otley; David Mack; Jeffrey Hyams; J de Bruijne; Krista Uusoue; Thomas D Walters; Mary Zachos; Petar Mamula; Dorcas E Beaton; A Hillary Steinhart; Anne M Griffiths
Journal:  Gastroenterology       Date:  2007-05-21       Impact factor: 22.682

7.  Obesity Is More Common in Children Newly Diagnosed With Ulcerative Colitis as Compared to Those With Crohn Disease.

Authors:  Abin Chandrakumar; Angus Wang; Kanika Grover; Wael El-Matary
Journal:  J Pediatr Gastroenterol Nutr       Date:  2020-05       Impact factor: 2.839

8.  Appraisal of the pediatric ulcerative colitis activity index (PUCAI).

Authors:  Dan Turner; Jeffrey Hyams; James Markowitz; Trudy Lerer; David R Mack; Jonathan Evans; Marian Pfefferkorn; Joel Rosh; Marsha Kay; Wallace Crandall; David Keljo; Anthony R Otley; Subra Kugathasan; Ryan Carvalho; Maria Oliva-Hemker; Christine Langton; Petar Mamula; Athos Bousvaros; Neal LeLeiko; Anne M Griffiths
Journal:  Inflamm Bowel Dis       Date:  2009-08       Impact factor: 5.325

9.  Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification.

Authors:  Arie Levine; Anne Griffiths; James Markowitz; David C Wilson; Dan Turner; Richard K Russell; John Fell; Frank M Ruemmele; Thomas Walters; Mary Sherlock; Marla Dubinsky; Jeffrey S Hyams
Journal:  Inflamm Bowel Dis       Date:  2010-11-08       Impact factor: 5.325

10.  Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition.

Authors:  Dan Turner; Frank M Ruemmele; Esther Orlanski-Meyer; Anne M Griffiths; Javier Martin de Carpi; Jiri Bronsky; Gabor Veres; Marina Aloi; Caterina Strisciuglio; Christian P Braegger; Amit Assa; Claudio Romano; Séamus Hussey; Michael Stanton; Mikko Pakarinen; Lissy de Ridder; Konstantinos Katsanos; Nick Croft; Victor Navas-López; David C Wilson; Sally Lawrence; Richard K Russell
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-08       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.